Clinical trials
Phase 1 Diabetes Mellitus, Type 2 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
374 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 5 |
| 2006 | 15 |
| 2007 | 16 |
| 2008 | 18 |
| 2009 | 44 |
| 2010 | 35 |
| 2011 | 34 |
| 2012 | 22 |
| 2013 | 24 |
| 2014 | 19 |
| 2015 | 11 |
| 2016 | 7 |
| 2017 | 15 |
| 2018 | 12 |
| 2019 | 8 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 12 |
| 2023 | 10 |
| 2024 | 13 |
| 2025 | 13 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 312 |
| Terminated | 26 |
| Recruiting | 22 |
| Active, not recruiting | 6 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 47 |
| Pfizer | 38 |
| GlaxoSmithKline | 34 |
| Eli Lilly and Company | 26 |
| Novo Nordisk A/S | 20 |
| Hoffmann-La Roche | 10 |
| Janssen Research & Development, LLC | 8 |
| Sanofi | 8 |
| The University of Texas Health Science Center at San Antonio | 7 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 374 |
| Diabetes Mellitus | 55 |
| Obesity | 35 |
| Insulin Resistance | 20 |
| Diabetes Mellitus, Type 1 | 13 |
| Overweight | 12 |
| Renal Insufficiency, Chronic | 8 |
| Glucose Metabolism Disorders | 7 |
| Renal Insufficiency | 6 |
| Weight Loss | 6 |
Trials
Showing 1 to 25 of 374. Each trial links to its page on Pharma Observatory.
274 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.